Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/10/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Daniel Hollander

Wrong Dr. Daniel Hollander?

Director, Scientific and Medical ...

Email: d***@***.org
Local Address: Los Angeles, California, United States
Company Description: Eli and Edythe Broad are lifelong philanthropists as founders of The Broad Foundations, which they established to advance entrepreneurship for the public good in...   more
Background

Employment History

Board Memberships and Affiliations

  • Member
    Western Association of Physicians

Education

  • M.D.
  • American Board of Gastroenterology
  • American Board of Internal Medicine
28 Total References
Web References
Staff - The Broad Foundation
www.broadfoundation.org, 7 Aug 2014 [cached]
Daniel Hollander, M.D. Director Scientific and Medical Research Initiatives
...
Daniel Hollander M.D. Director
How to Apply - Broad Foundation Scientific | Medical Research
www.broadmedical.org, 3 Jan 2014 [cached]
Daniel Hollander, M.D. Director Broad Medical Research Program The Eli and Edythe Broad Foundation, Scientific | Medical Research 10900 Wilshire Boulevard, Twelfth Floor Los Angeles, California 90024-6532 U.S.A.
The Eli and Edythe L. Broad Foundation Create Grant Program for Inflammatory Bowel Disease - Broad Foundation Scientific | Medical Research
www.broadmedical.org, 2 Nov 2001 [cached]
Daniel Hollander, M.D. to Lead Innovative Research Effort
Funding Available to Expand on Recent Advances in Crohn's Disease Research
...
Daniel Hollander, M.D. has been named the Director of the program.
...
Dr. Hollander is a widely recognized expert in this field for his visionary work on IBD. I am honored that he is committing his time and efforts to finding improved therapy and prevention of IBD."
"In light of recent genetic discoveries regarding Crohn's disease, I am excited about the opportunities these grants will provide to investigators working in IBD research," Dr. Hollander said.
...
Hollander is a Professor of Medicine at the University of California, Los Angeles School of Medicine. Before joining the BMRP, he was President/CEO of the Harbor-UCLA Research and Education Institute. Hollander has held several academic leadership positions including: Executive Dean and Professor of Medicine at the University of Kansas School of Medicine, and Professor of Medicine and Head, Division of Gastroenterology at the University of California, Irvine (UCI).
While at UCI, he also served as Associate Dean for Research and Program Development, Associate Dean for Academic Affairs and Senior Associate Dean for Clinical Affairs. Hollander is a member of the American Society for Clinical Investigation, the American College of Physicians, the American Federation for Medical Research, the American Gastroenterological Association, the American Physiological Society and the Western Association of Physicians.
He is a diplomate of the American Board of Internal Medicine and the American Board of Gastroenterology. He has conducted research on the pathogenesis of Crohn's disease, as well as on nutrient lipid absorption and the influence of aging on intestinal functions.
Area Biotech Firm Passes FDA Test | Quantimetrix
quantimetrix.com, 12 June 2013 [cached]
Winning FDA approval for a medical device or procedure is a major challenge, said Daniel Hollander, president and CEO of the Harbor-UCLA Research and Education Institute in Torrance.
"It's very difficult because they really have to go through incredible hoops," Hollander said. "They have to prove not only the reliability of the process but its innovation so that it doesn't duplicate other processes. And they have to prove its safety."
But that's just the first of many obstacles for the company, Hollander said.
"There are many ways to assess lipoprotein (cholesterol)," he said.
...
But Hollander said new locally made products, such as Quantimetrix's Lipoprint System, could help boost the profile of Los Angeles in the biotech industry. "Every little bit counts," Hollander said.
Program Staff - Broad Foundation Scientific | Medical Research
www.broadmedical.org, 3 Jan 2014 [cached]
Daniel Hollander, M.D. is the director of the scientific and medical research initiatives of The Broad Foundation and a professor of medicine at the University of California, Los Angeles (UCLA) School of Medicine. Before joining The Broad Foundation, he was president/CEO of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Dr. Hollander has held several academic leadership positions including executive dean and professor of medicine at the University of Kansas School of Medicine and head of the Division of Gastroenterology at the University of California, Irvine (UCI). While at UCI, he also served as associate dean for research and program development, associate dean for academic affairs and senior associate dean for clinical affairs.
Other People with the name "Hollander":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304